At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Mar 3, 2026 at 18:01 ET
ANI Pharmaceuticals CFO Stephen P. Carey surrendered 5,150 shares to cover tax obligations in connection with a vesting event, valued at $381,306. This was a non-cash transaction related to equity compensation and not an open-market sale or discretionary trade.
- CFO Stephen P. Carey surrendered 5,150 shares at $74.04 per share for tax withholding purposes
- Transaction value: $381,306
- This is a non-cash, automatic disposition (Form 4 code 'F'), not an open-market sale or discretionary sell
- Only one insider involved: CFO (C-suite), but transaction driven by tax rules, not sentiment
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access